Literature DB >> 12579118

Successful clinical application of tissue-engineered graft for extracardiac Fontan operation.

Yuji Naito1, Yasuharu Imai, Toshiharu Shin'oka, Junichi Kashiwagi, Mitsuru Aoki, Manabu Watanabe, Goki Matsumura, Yoshimichi Kosaka, Takeshi Konuma, Narutoshi Hibino, Akira Murata, Takeshi Miyake, Hiromi Kurosawa.   

Abstract

Mesh：

Year:  2003        PMID： 12579118     DOI： 10.1067/mtc.2003.134

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  25 in total

1.  In vivo performance of a phospholipid-coated bioerodable elastomeric graft for small-diameter vascular applications.

Authors:  Lorenzo Soletti; Alejandro Nieponice; Yi Hong; Sang-Ho Ye; John J Stankus; William R Wagner; David A Vorp
Journal:  J Biomed Mater Res A       Date:  2010-12-09       Impact factor: 4.396

Review 2.  Cardiovascular Tissue Engineering: Preclinical Validation to Bedside Application.

Authors:  Cameron Best; Ekene Onwuka; Victoria Pepper; Malik Sams; Jake Breuer; Christopher Breuer
Journal:  Physiology (Bethesda)       Date:  2016-01

Review 3.  Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again.

Authors:  Joseph T Patterson; Thomas Gilliland; Mark W Maxfield; Spencer Church; Yuji Naito; Toshiharu Shinoka; Christopher K Breuer
Journal:  Regen Med       Date:  2012-05       Impact factor: 3.806

Review 4.  Challenges in tissue engineering.

Authors:  Yoshito Ikada
Journal:  J R Soc Interface       Date:  2006-10-22       Impact factor: 4.118

5.  Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis.

Authors:  Gabriel J M Mirhaidari; Jenny C Barker; Jacob C Zbinden; Brevan M Santantonio; Yu-Chun Chang; Cameron A Best; James W Reinhardt; Kevin M Blum; Tai Yi; Christopher K Breuer
Journal:  Adv Healthc Mater       Date:  2020-10-19       Impact factor: 9.933

6.  A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts.

Authors:  Narutoshi Hibino; Tai Yi; Daniel R Duncan; Animesh Rathore; Ethan Dean; Yuji Naito; Alan Dardik; Themis Kyriakides; Joseph Madri; Jordan S Pober; Toshiharu Shinoka; Christopher K Breuer
Journal:  FASEB J       Date:  2011-08-24       Impact factor: 5.191

7.  Differentiation from embryonic stem cells to vascular wall cells under in vitro pulsatile flow loading.

Authors:  Haiying Huang; Yasuhide Nakayama; Kairong Qin; Kimiko Yamamoto; Joji Ando; Jun Yamashita; Hiroshi Itoh; Keiichi Kanda; Hitoshi Yaku; Yoshihiro Okamoto; Yasushi Nemoto
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

Review 8.  Translational Challenges in Cardiovascular Tissue Engineering.

Authors:  Maximilian Y Emmert; Emanuela S Fioretta; Simon P Hoerstrup
Journal:  J Cardiovasc Transl Res       Date:  2017-03-09       Impact factor: 4.132

9.  Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts.

Authors:  Juan de Dios Ruiz-Rosado; Yong-Ung Lee; Nathan Mahler; Tai Yi; Frank Robledo-Avila; Diana Martinez-Saucedo; Avione Y Lee; Toshihiro Shoji; Eric Heuer; Andrew R Yates; Jordan S Pober; Toshiharu Shinoka; Santiago Partida-Sanchez; Christopher K Breuer
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

10.  Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique.

Authors:  Alejandro Nieponice; Lorenzo Soletti; Jianjun Guan; Bridget M Deasy; Johnny Huard; William R Wagner; David A Vorp
Journal:  Biomaterials       Date:  2007-11-26       Impact factor: 12.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.